Sars, Carl http://orcid.org/0000-0003-1691-8871
Sackey, Helena
Frisell, Jan
Dickman, Paul W.
Karlsson, Fredrik
Kindts, Isabelle
Marta, Gustavo Nader
Freitas-Junior, Ruffo
Tvedskov, Tove Filtenborg
Kassem, Loay
Ali, Ahmed S.
Ihalainen, Hanna
Neron, Mathias
Kontos, Michalis
Kaidar-Person, Orit
Meattini, Icro
Francken, Anne Brecht
van Duijnhoven, Frederieke
Moberg, Ingvild Ona
Marinko, Tanja
Kollar, Attila
Ahmed, Mahbubl
Remoundos, Dennis
Banks, Jenny
Jagsi, Reshma
Dossett, Lesly A.
Lindqvist, Ebba K.
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 29 November 2022
Accepted: 14 February 2023
First Online: 6 March 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose. Outside the submitted work, RJ has stock options as compensation for her advisory board role in Equity Quotient, a company that evaluates culture in health care companies; she has received personal fees from the Greenwall Foundation, Doris Duke Charitable Foundation, and the National Institutes of Health and grants or contracts for unrelated work from the National Institutes of Health, the Doris Duke Charitable Foundation, the American Cancer Society, the Greenwall Foundation, Genentech, and Blue Cross Blue Shield of Michigan. She has served as an expert witness for Sherinian and Hasso, Dressman Benzinger LaVelle, and Kleinbard, LLC.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Swedish Ethical Review Authority (Dnr 2020–03335), the Finnish Ethical Review Authority, the Brazilian Ethical Review Authority (CAAE: 47661921.9.0000.5461/number 4.787.791), and the American Ethical Review Authority. For additional participating countries, ethical permit was waived according to national regulations and/or local ethical review boards.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.